CClinicalTrials.gg
CompletedNCT01180842Updated Feb 14, 2014

Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)

A Phase 2 interventional study of Yoga treatment program in Cystic Fibrosis, sponsored by Children's Hospitals and Clinics of Minnesota. Completed at 1 site in United States. Open to participants aged 9 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-02-14.

Sponsored by Children's Hospitals and Clinics of Minnesota · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
9 Years to 18 Years
Sex
All
01

Study summary

The investigators research question is whether or not yoga effectively alleviates symptoms of pain, sleep disturbance, anxiety and depression in children with cystic fibrosis. If yoga does prove to be effective, the investigators will educate our CF population about the benefits they may experience if they choose to incorporate yoga into their CF therapy. The investigators will also go on to do further research of other complementary alternative medicine therapies.

This is a pre/post-test study with 20 subjects. The subjects will serve as their own controls. Each subject will participate in six yoga sessions over a ten week period. Subjects' symptoms will be evaluated with the use of questionnaires. The investigators will also test cortisol levels on weeks -2, -1, 1, 6, 7, 8. Cortisol is a hormone that is affected by stress. Testing of cortisol throughout the study will help us determine the subjects' stress level throughout the study.

Read the detailed description

H1: The implementation of a yoga therapy program decreases symptoms of pain within our CF population.

H2: The implementation of a yoga therapy program decreases symptoms of sleep disturbance within our CF population.

H3: The implementation of a yoga therapy program decreases symptoms of anxiety within our CF population.

H4: The implementation of a yoga therapy program decreases symptoms of depression within our CF population.

02

Conditions studied

  • Cystic Fibrosis

Keywords

  • CF
03

In context

Cystic Fibrosis

1,581 studies on the registry are indexed under Cystic Fibrosis; 190 are open to participants now.

This study's enrollment of 20 is below the median of 36 across 1,034 interventional studies indexed under Cystic Fibrosis.

Browse Cystic Fibrosis studies →

Lead sponsor

Children's Hospitals and Clinics of Minnesota is the lead sponsor of 49 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Positive diagnosis of CF
  • Males or females within the ages of 9 and 18

Exclusion criteria

Exclusion Criteria:

  • No positive diagnosis of CF
  • Younger than 9 years of age or older than 18 years of age
  • Concomitant illness or disease that may inhibit the patient's ability to participate in the study as determined by the principal investigator
  • The patient has participated in an investigational treatment study 30 days prior to pre-session week -2.
  • The patient is currently participating in yoga sessions one or more times per week.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Other
    Alternative Treatment

    The CF Patient Population receiving the specific yoga study treatment

    Other: Yoga treatment program

Interventions

  • OtherYoga treatment program

    yoga program designed specifically for the patient with CF

06

What researchers measure

Primary outcomes

  1. Improve Quality of Life measured through self report questionnaires

    Tool: CFQ-R

    Time frame: We expect this study to last one year.

Secondary outcomes

  1. Reduce symptoms of pain measured through self report questionnaires

    Tools: 1) MSAS and 2)Additional Pain Symptoms Questions

    Time frame: 1 year

  2. Reduce symptoms of anxiety measured through self report questionnaires and cortisol testing

    Assessed through 1)Saliva cortisol testing and 2)tools:STAIC and HADS

    Time frame: 1 year

  3. Reduce symptoms of sleep disturbance measured through self report questionnaires

    tools: 1)MSAS and 2)CES-DC

    Time frame: 1 year

  4. Reduce symptoms of depression measured through self report questionnaires and cortisol testing

    tools: 1)CES-DC, 2) HADS and 3) saliva cortisol testing

    Time frame: 1 year

07

Study locations

1 site
  • Children's Hospitals and Clinics of Minnesota
    Minneapolis, Minnesota 55404, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 14, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01180842
Lead sponsor
Children's Hospitals and Clinics of Minnesota
Responsible party
Sponsor
First posted
Aug 12, 2010
Start date
Mar 2010
Primary completion
Dec 2013
Completion
Dec 2013
Last update
Feb 14, 2014

Study contacts

John McNamara, MD
principal investigator · Children's Hospitals and Clinics of Minnesota

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion